J Rheum Dis.  2023 Jul;30(3):139-140. 10.4078/jrd.2023.0033.

Are nonsteroidal anti-inflammatory drugs safe for the kidney in ankylosing spondylitis?

• Kim JW

• KMID: 2543940
• DOI: http://doi.org/10.4078/jrd.2023.0033

Reference

1. Harty T, O'Shaughnessy M, Harney S. 2023; Therapeutics in rheumatology and the kidney. Rheumatology (Oxford). 62:1009–20. DOI: 10.1093/rheumatology/keac460. PMID: 35951751.

2. Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, et al. 2007; NSAID use and progression of chronic kidney disease. Am J Med. 120:280.e1–7. DOI: 10.1016/j.amjmed.2006.02.015. PMID: 17349452.

3. Nelson DA, Marks ES, Deuster PA, O'Connor FG, Kurina LM. 2019; Association of nonsteroidal anti-inflammatory drug prescriptions with kidney disease among active young and middle-aged adults. JAMA Netw Open. 2:e187896. DOI: 10.1001/jamanetworkopen.2018.7896. PMID: 30768191. PMCID: PMC6484592.

4. Koo BS, Hwang S, Park SY, Shin JH, Kim TH. 2023; The relationship between long-term use of nonsteroidal anti-inflammatory drugs and kidney function in patients with ankylosing spondylitis. J Rheum Dis. 30:126–32. DOI: 10.4078/jrd.2023.0006.

5. Kristensen LE, Jakobsen AK, Askling J, Nilsson F, Jacobsson LT. 2015; Safety of etoricoxib, celecoxib, and nonselective nonsteroidal antiinflammatory drugs in ankylosing spondylitis and other spondyloarthritis patients: a Swedish national population-based cohort study. Arthritis Care Res (Hoboken). 67:1137–49. DOI: 10.1002/acr.22555. PMID: 25623277.

6. Couderc M, Pereira B, Molto A, Tiple A, Soubrier M, Dougados M. 2018; The prevalence of renal impairment in patients with spondyloarthritis: results from the international ASAS-COMOSPA study. J Rheumatol. 45:795–801. DOI: 10.3899/jrheum.170133. PMID: 29657148.

7. Möller B, Pruijm M, Adler S, Scherer A, Villiger PM, Finckh A. 2015; Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis. 74:718–23. DOI: 10.1136/annrheumdis-2013-204078. PMID: 24356672.

8. Swart IAP, Visman IM, Heslinga M, van der Horst-Bruinsma IE, van Denderen JC, Nurmohamed MT. 2022; The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study. Clin Rheumatol. 41:3747–52. DOI: 10.1007/s10067-022-06330-9. PMID: 35962246. PMCID: PMC9652256.

9. Dougados M, Simon P, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, et al. 2011; ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis. 70:249–51. DOI: 10.1136/ard.2010.133488. PMID: 20829199.

10. Obeid S, Libby P, Husni E, Wang Q, Wisniewski LM, Davey DA, et al. 2022; Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial. Eur Heart J Cardiovasc Pharmacother. 8:611–21. DOI: 10.1093/ehjcvp/pvac015. PMID: 35234840.